1. 364OClinical utility of ctDNA genomic alterations (GA) based on ESMO scale for clinical actionability of molecular targets (ESCAT) in advanced NSCLC. (24th November 2019) Authors: Mezquita, L; Planchard, D; Suarez, M Dorta; Aldea, M; Naltet, C; Lamberts, V; Grecea, M; Martin-Romano, P; de Kievit, F; Jovelet, C; Lacroix, L; Masip, J Remon; Lavaud, P; Gazzah, A; Morris, C; Howarth, K; Green, E; Vassal, G; Massard, C; Besse, B Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗